September 12, 2014 by Brad Perriello
ReWalk Robotics prices its initial public offering at $12 a share, under its prior range, raising $36 million for its exoskeleton for spinal cord injury patients
ReWalk Robotics (NSDQ:RWLK) priced its initial public offering below its forecast range, at $12 per share, grossing some $36.0 million for its exo-skeleton suit.
ReWalk, formerly known as Argo Medical Technologies, initially forecast a range of $14 – $16 per share for the 3.4-million-share IPO. That would have raised $47.6 million to $54.4 million; instead, at $12 apiece for 3 million shares, the offering brought in $36 million, according to a regulatory filing.
